Samsung Medical Center: Small Cell Lung Carcinoma trials

The registry lists 10 Small Cell Lung Carcinoma studies with Samsung Medical Center as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 8Phase 3 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Chemoradiation With Durvalumab Followed by Durvalumab Maintenance for Limited Disease Small Cell Lung CancerStatus unknownNCT03585998Phase 2
• Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2]CompletedNCT03428607Phase 2
• AZD 2811 Monotherapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N3]TerminatedNCT03366675Phase 2
• Vistusertib (AZD2014) Monotherapy in Relapsed Small Cell Lung Cancer Patients Harboring RICTOR AmplificationTerminatedNCT03106155Phase 2
• Olaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A MutationsCompletedNCT03009682Phase 2
• Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 MutationTerminatedNCT02688907Phase 2
• Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer PatientsCompletedNCT02593019Phase 2
• Pazopanib Maintenance for SCLCCompletedNCT01797874Phase 2
• Early Versus Late Concurrent Chemoradiation for Limited Stage Small-cell Lung CancerCompletedNCT01125995Phase 3
• Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung CancerCompletedNCT01079481Phase 1